United States Restricted Access Barrier System (Pharmaceutical, Chemical Manufacturing, Medical) market research report 2021 – ResearchAndMarkets.com



DUBLIN – (COMMERCIAL THREAD) – The report “United States Restricted Access Barrier Systems Market Size, Share and Trend Analysis Report by Application (Pharmaceutical, Chemical Manufacturing, Medical) and Segment Forecast, 2020-2028 »has been added to ResearchAndMarkets.com offer.

The United States Restricted Access Barrier Systems market size is expected to reach USD 249.4 million by 2028 and is expected to grow at a CAGR of 4.7% from 2020 to 2028.

The market is primarily driven by the growth of the biotechnology industry in the United States due to technological advancements, the growing number of small biopharmaceutical companies, and increasing investment in research.

Technological breakthroughs in biopharmaceutical and biotechnology manufacturing are expected to drive the market growth during the forecast period. The demand for modular equipment capable of reducing the time required for drug production and minimizing the overall production cost is expected to provide a major boost to the market growth in the United States.

The COVID-19 pandemic has restored the importance of collaborations; many life science companies are joining forces to improve biotechnology R&D. The pandemic has accelerated the need for sustainability, energy conservation, and green pharmaceutical manufacturing, thereby influencing product development in the Restricted Access Barrier Systems (RABS) market.

A growing trend towards contract development and manufacturing organization (CDMO) for aseptic manufacturing is expected to increase the demand for RABS. Contract manufacturers such as Aenova Group, DPT Laboratories and Recipharm AB are focusing on new contracts in the United States, which has a positive impact on the growth of the market.

Highlights of the United States Restricted Access Barrier Systems Market Report

  • Pharmaceutical applications segment accounted for the largest share of 64.5% in 2020 due to the growth of the pharmaceutical industry in the United States coupled with advantages such as faster changeover process and easy handling.

  • The medical applications segment is expected to grow at a CAGR of 3.9% from 2020 to 2028. This is attributed to the increasing penetration of RABS in this segment due to its ability to provide septic safety in the critical area and flexibility. interventions.

  • The US government aims to reduce reliance on drugs manufactured outside the United States by encouraging drug companies to set up manufacturing facilities in the United States, thereby increasing the demand for RABS.

  • In February 2021, Comecer spA partnered with Illuminate Manufacturing Intelligence, a division of ATS (ATA.TO), to develop a production solution integrating its portfolio of containment equipment in accordance with Industry 4.0.

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Variables, Trends and Scope of the United States Restricted Access Barrier Systems Market

Chapter 4 United States Restricted Access Barrier Systems Market: Application Estimates and Trend Analysis

Chapter 5 Competitive Landscape

  • IMA Industria Macchine Automatiche SPA

  • Germ Free Laboratories, Inc.

  • Extraction technology


  • Syntegon Technologies GmbH

  • Isolation Systems Inc.

  • Shanghai Tofflon Science and Technology Co., Ltd.

  • Ortner Reinraumtechnik GmbH



For more information on this report, visit https://www.researchandmarkets.com/r/d41t1g



Comments are closed.